The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

Abstract

This analysis predicts that the current HK vaccination strategy can be considered cost-effective and will provide maximum health benefit. These results support addition of the routine 9vHPV vaccine with or without catch-up 9vHPV vaccination to the regional vaccination program in HK.